Fig 1 is incorrect. Please see the correct Fig 1 here. The publisher apologizes for the error.
Fig 1. PRISMA flow diagram according to [50] summarising study selection for clinical trials reporting safety (left) and efficacy (right) outcomes, respectively.
Search terms employed were: methotrexate [Title] AND (psoriasis [Title] OR arthritis [Title] OR Crohn’s [Title] OR ulcerative colitis [Title] OR ankylosing spondylitis [Title]) AND (trial [Title] OR Study [Title]) for safety studies and: Search: methotrexate [Title] AND psoriasis [Title] AND (trial [Title] OR Study [Title]) for efficacy studies.
Reference
- 1.West J, Ogston S, Foerster J (2016) Safety and Efficacy of Methotrexate in Psoriasis: A Meta-Analysis of Published Trials. PLoS ONE 11(5): e0153740 doi: 10.1371/journal.pone.0153740 [DOI] [PMC free article] [PubMed] [Google Scholar]

